Jul 18, 2018 - Novartis (NVS) misses on Q2 earnings but beats sales on the back of continued momentum from Cosentyx and Entresto. Oncology franchise also exhibits strong growth.
Aug 14, 2018 - Known as a mega-round in Silicon Valley, large-scale fund raising is producing a frenzy around tech companies with enough reach and momentum to absorb a large check.
Sep 18, 2018 - Trade War Once Again Gather Steam
Sep 24, 2018 - Novartis (NVS) gets positive CHMP opinion for a label expansion of Gilenya, gene therapy, and a biosimilar of Neulasta.
Oct 10, 2018 - Novartis (NVS) announces positive results from a post hoc analysis of the phase II study, SUSTAIN, on pipeline candidate, crizanlizumab, being published in the American Journal of Hematology.
Nov 16, 2018 - uniQure's (QURE) gene therapy candidate, AMT-061, demonstrates significant improvement in hemophilia B patients in a mid-stage study. Investors' sentiment improves.
Nov 28, 2018 - Pipeline and regulatory updates are the key highlights in the biotech sector this week.
Feb 26, 2019 - Gene therapy stocks have not only soared on Roche-Spark deal news but are also poised to make the most of the next gene revolution.
Feb 27, 2019 - Key highlights of the past week are merger agreements, and regulatory and pipeline developments.
Mar 05, 2019 - Biogen (BIIB) to acquire gene-therapy company, Nightstar Therapeutics to accelerate entry into ophthalmology space.